Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study.

E Ciuleanu, A Irimie, TE Ciuleanu, V Popita… - Journal of BU ON …, 2008 - europepmc.org
Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
被引用次数：49 相关文章

Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study

E Ciuleanu, A Irimie, TE Ciuleanu… - Journal of BU ON …, 2008 - pubmed.ncbi.nlm.nih.gov
Purpose To evaluate the efficacy of capecitabine (Xeloda) as rescue treatment (2nd, 3rd and
4th line) in patients with relapsed nasopharyngeal carcinoma (NPC) in a phase II study …